MissionIR Articles

Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including…

Tonix Pharmaceuticals Holding is focused on the development of innovative prescription medicines for challenging disorders of the central nervous system. Tonix targets conditions characterized by significant unmet medical need, inadequate existing treatments and high patient…

Palatin Technologies is a biopharmaceutical company engaged in the development of targeted, receptor-specific peptide therapeutics for treating diseases that have significant unmet medical need but where there is also commercial potential. The company’s strategy involves…

Lexicon Pharmaceuticals is a biopharmaceutical company engaged in the discovery of breakthrough treatments for human disease. Currently, the company has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid…

CEL-SCI is a biotechnology company engaged in research and development directed toward improving treatments for cancer and other diseases through utilization of the immune system – the body’s natural defense system. Multikine, the company’s lead…

Repros Therapeutics is a development-stage biopharmaceutical company focused on developing oral small molecule drugs to address major unmet medical needs for male and female reproductive disorders. The company’s primary product candidate is Androxal, an orally…

GENFIT is a biopharmaceutical company at the forefront of drug discovery and development. The company’s focus is on the early diagnosis and preventive treatment of cardiometabolic and associated disorders. GENFIT’s mission is bringing therapeutic and…

NPS Pharmaceuticals is a biopharmaceutical company engaged in bringing orphan products to patients who have rare disorders and few, if any, therapeutic options. The FDA-approved Gattex 0.05 mg/kg/d for subcutaneous injection is the company’s lead…

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase the value of drug development programs, cost-efficiently advancing them through the drug discovery and development process. The company’s…

ReNeuron Group is a clinical-stage stem cell leader primarily focused on developing novel stem cell therapies to target areas of important unmet or inadequately met medical need. The company has used its stem cell technologies…

Rigel Pharmaceuticals is a clinical-stage drug development company engaged in the discovery and development of novel, small-molecule drugs to treat inflammatory and autoimmune diseases and muscle disorders. The company’s groundbreaking research is focused on intracellular…

ImmunoCellular Therapeutics is a clinical-stage company focused on the development of immune-based therapies for treating brain and other cancers. The company is conducting a Phase II trial of its lead product candidate ICT-107, which is…

DiaMedica is a biotechnology company engaged in the development of first-in-class treatments for diabetes. DM-199, the company’s lead compound, is a recombinant human protein for treating both Type 1 and Type 2 diabetes and their…

Advanced Cell Technology is a biotechnology company focused on the application of cellular technology in the field of regenerative medicine. The company specializes in developing cellular therapies to treat diseases and conditions impacting tens of…

Transition Therapeutics is a biopharmaceutical company focused on the development of novel therapeutics for disease indications with large markets. The company’s lead product, ELND005, is a treatment for Alzheimer’s disease and bipolar disorder. Transition additionally…

ChemoCentryx is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of orally administered therapeutics targeting the chemokine and chemoattractant systems to treat autoimmune diseases, inflammatory disorders and cancer. The company has generated…

Oncolytics Biotech is a biotechnology company engaged in developing oncolytic viruses as potential therapeutics for cancer. Based in Calgary, Canada, the company has a clinical program that includes various human trials, such as a Phase…

Verastem is a clinical-stage biopharmaceutical company engaged in discovering and developing drugs to treat cancer through targeted killing of cancer stem cells, which are an underlying cause of tumor recurrence and metastasis. The company is…

GTx is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for treating cancer, for cancer supportive care and for other serious medical conditions. The company’s most advanced drug discovery and…